Schedule 13D ownership disclosure

TARO PHARMACEUTICAL INDUSTRIES LTD

Security class unavailable · CUSIP: M8737E108

Event date: 2023-05-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
78.4800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950103-23-007957
Form type
SC 13D/A
Filer
SUN PHARMACEUTICAL INDUSTRIES LTD
CIK
CIK 1197089
Filed
May 26, 2023
Reporting period
May 26, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub